WS

West Pharmaceutical Services IncNYSE WST Stock Report

Last reporting period 30 Sep, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

22.467

Large

Exchange

XNYS - New York Stock Exchange, Inc

View Section: Eyestock Rating

West Pharmaceutical Fair Value

WS

The fair market value of WST stock is 327.1 USD. Relative to the market price of 342.705 USD West Pharmaceutical is overvalued by 4.6%

Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.

Fair Relative Value

Overvalued 4.6%
327.1 USD
WST Fair Value
342.7 USD
Market price of WST

West Pharmaceutical Valuation

Current WST share ticker price is 342.705 USD.

The fair value level of 327.1 USD can be considered as an effective entry point for long-term investors to start investing in WST stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Current price is 5% higher its fair value

Min value

Current price is 24% higher its minimum value

Max value

Current price is 13% lower its maximum value

14.11.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

WST stock is overvalued

It means the current price may concern as a Risky Entry Point

West Pharmaceutical Services Inc Stock Valuation Calculator

How do we value a stock?

As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.

1

Maximum P/E over 5 years

56.63

2

Median P/E over 5 years

47.9

3

Minimum P/E over 5 years

37.91

4

Earning per share (last 12 months)

6.83 USD

Maximum value

1

x

4

=

386.77 USD

Fair value

2

x

4

=

327.1 USD

Minimum value

3

x

4

=

258.87 USD

West Pharmaceutical Services Inc price metrics

17.1

Annual return (geometric mean)

35.21

Risk (standard deviation) of returns

β

1.01

Beta (volatility compared to market)

It means that WST stock is more volatile than the broader market

Discover Undervalued Companies


View Section: Profitability